生物技术中的人工智慧市场：按组件、按应用、按最终用户、按地区

预计2024年全球人工智慧在生物技术市场的规模将达到21亿美元，预计到2031年将达到71.1亿美元，2024年至2031年的复合年增长率为19%。

图：2024 年人工智慧在生物技术领域的市场占有率（%），按地区划分

由于人工智慧和机器学习等各个领域的技术发展，生物技术领域正在快速发展。生物技术领域越来越多地在从药物发现和基因组分析到临床试验监测和精准医疗的各个领域利用人工智慧。人工智慧工具正在帮助研究人员处理大量基因组和资料，资料获得对疾病机制的新见解。深度学习、神经网路和自然语言处理等多种人工智慧驱动的技术可以透过支援标靶识别、先导药物最适化、毒性预测和生物标记发现等关键功能来显着加速药物开发过程。人工智慧可以帮助生物技术公司更有效地监控和管理临床试验。它还有望应用于个人化医疗，支持根据每位患者的遗传特征和病历定制的治疗提案。全球人工智慧在生物技术市场的成长是由这些技术在製药/生物技术产业和医疗保健中越来越多的采用所推动的。

市场动态：

全球人工智慧在生物技术市场的成长是由人工智慧新兴企业的资金增加所推动的，这些新创公司开发医疗保健和生命科学解决方案、需要高级分析和患者生成的复杂生物资料，这是由新兴市场扩张等资料推动的。然而，缺乏熟练劳动力、资料品质问题以及与人工智慧和巨量资料相关的安全和监管问题等因素可能会阻碍其采用。预测分析、机器学习和人工智慧在精准医学、个人化治疗、基因治疗和诊断中的扩展应用可以为市场成长提供机会。

本研究的主要特点

• 本报告对全球生物技术领域的人工智慧市场进行了详细分析，并给出了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
• 它还揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
• 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球生物技术市场人工智慧的主要企业。
• 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 生物技术人工智慧全球市场报告迎合了该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进入者和财务分析师。

目录

第一章 研究目的与前提

• 研究目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• 一致的机会地图 (COM)

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球人工智慧在生物技术市场中－冠状病毒（COVID-19）大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章 2019-2031 年生物技术领域的人工智慧市场（按组成部分）（十亿美元）

• 介绍
• 软体
• 硬体
• 服务

第六章 2019-2031 年生物技术领域的人工智慧市场（按应用分类）（十亿美元）

• 介绍
• 药物发现与开发
• 临床试验和优化
• 医学影像
• 诊断
• 其他的

第 7 章 生物技术领域的人工智慧市场，按最终用户划分，2019-2031 年（十亿美元）

• 介绍
• 製药公司
• 生技公司
• 学术研究所
• 医疗提供者
• CRO 和 CDMO
• 其他的

第八章 生物技术市场中的人工智慧，按地区划分，2019-2031（十亿美元）

• 介绍
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东

第9章 竞争格局

• 公司简介
  • AstraZeneca
  • Bristol-Myers Squibb
  • Gilead Sciences, Inc.
  • Sanofi
  • Abbott Laboratories
  • Biogen
  • Pfizer, Inc.
  • Novo Nordisk A/S
  • Amgen, Inc.
  • Merck KGaA
  • Johnson &Johnson Services, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Deep Genomics
  • NVIDIA Corporation
  • Verge Genomics
  • Recursion Pharmaceuticals

第10章分析师建议

• 上升和下降
• 综合机会图

第十一章 参考文献与调查方法

• 参考
• 调查方法

Global AI in biotechnology market is estimated to be valued at USD 2.10 Bn in 2024 and is expected to reach USD 7.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 19% from 2024 to 2031.

Figure. Artificial Intelligence (AI) in Biotechnology Market Share (%), By Region 2024

The field of biotechnology has witnessed rapid advancements due to technological developments in various domains including artificial intelligence and machine learning. AI is being increasingly used in biotechnology for applications ranging from drug discovery and genome analysis to clinical trial monitoring and precision medicine. AI tools help researchers to process huge volumes of genomic and proteomic data and gain novel insights into disease mechanisms. Several AI-powered techniques like deep learning, neural networks, natural language processing, and others assist in critical functions like target identification, lead optimization, toxicity prediction and biomarker discovery, thus, significantly accelerating the drug development process. AI help biotech companies in monitoring and managing clinical trials more efficiently. It also has promising applications in personalized medicine by supporting treatment recommendations tailored to individual patients' genetic profile and medical history. Global AI in biotechnology market growth is driven by rising adoption of these technologies in pharma/biotech industry and healthcare.

Market Dynamic:

Global AI in biotechnology market growth is driven by factors like increasing funding for AI startups developing solutions for healthcare and life sciences, growing volumes of complex biological and patient-generated healthcare data requiring sophisticated analysis, and rising need to enhance R&D productivity and reduce costs in drug discovery. However, factors like lack of skilled workforce, data quality issues, security and regulatory concerns related to AI and big data can hamper its adoption. Expanding applications of predictive analytics, machine learning and artificial intelligence in precision medicine, personalized therapeutics, gene therapies and diagnostics can offer market growth opportunities.

Key Features of the Study:

• This report provides in-depth analysis of the global AI in biotechnology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global AI in biotechnology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Intel Corporation, NVIDIA Corporation, IBM Corporation, Microsoft Corporation, Amazon Web Services, Anthropic, Berg Health, Deep Genomics, Enlitic, twoXAR, and Insilico Medicine
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global AI in biotechnology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation-

• By Component
  • Software
  • Hardware
  • Services
• By Application
  • Drug Discovery & Development
  • Clinical Trials & Optimization
  • Medical Imaging
  • Diagnostics
  • Others
• By End User
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic & Research Institutes
  • Healthcare Providers
  • CRO & CDMO
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AstraZeneca
  • Bristol-Myers Squibb
  • Gilead Sciences, Inc.
  • Sanofi
  • Abbott Laboratories
  • Biogen
  • Pfizer, Inc.
  • Novo Nordisk A/S
  • Amgen, Inc.
  • Merck KGaA
  • Johnson & Johnson Services, Inc.
  • Hoffmann-La Roche Ltd.
  • Novartis AG
  • Deep Genomics
  • NVIDIA Corporation
  • Verge Genomics
  • Recursion Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Component
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global AI in Biotechnology Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global AI in Biotechnology Market, By Component, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Software
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hardware
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Services
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global AI in Biotechnology Market, By Application, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Drug Discovery & Development
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Clinical Trials & Optimization
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Medical Imaging
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Diagnostics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global AI in Biotechnology Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Pharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Biotechnology Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Academic & Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Healthcare Providers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• CRO & CDMO
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global AI in Biotechnology Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bristol-Myers Squibb
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Gilead Sciences, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott Laboratories
  • Biogen
  • Pfizer, Inc.
  • Novo Nordisk A/S
  • Amgen, Inc.
  • Merck KGaA
  • Johnson & Johnson Services, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Deep Genomics
  • NVIDIA Corporation
  • Verge Genomics
  • Recursion Pharmaceuticals

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact